Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.
Artificially intelligent tools are revolutionizing nearly
every stage of the drug discovery process, offering substantial
potential to reshape the speed and economics of the industry. As
the drug discovery and preclinical stages speed up and potentially
produce more drugs to test in the clinical trial phase,
how...
Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.